• Home

  • Documents

  • health.krhealth.kr/images/insert_pdf/IN_A11AOOOOO8538_00.pdf*acetin vs 40 20 300 Dose (mg/day)...
4

health.krhealth.kr/images/insert_pdf/IN_A11AOOOOO8538_00.pdf*acetin vs 40 20 300 Dose (mg/day) significant ßhown study E3 4396* my/duj 601) mg/dhy p 00001 Study El BID study E2 study

  • Upload
    donhi

  • View
    213

  • Download
    0

Embed Size (px)

Citation preview

Page 1: health.krhealth.kr/images/insert_pdf/IN_A11AOOOOO8538_00.pdf*acetin vs 40 20 300 Dose (mg/day) significant ßhown study E3 4396* my/duj 601) mg/dhy p 00001 Study El BID study E2 study
Page 2: health.krhealth.kr/images/insert_pdf/IN_A11AOOOOO8538_00.pdf*acetin vs 40 20 300 Dose (mg/day) significant ßhown study E3 4396* my/duj 601) mg/dhy p 00001 Study El BID study E2 study
Page 3: health.krhealth.kr/images/insert_pdf/IN_A11AOOOOO8538_00.pdf*acetin vs 40 20 300 Dose (mg/day) significant ßhown study E3 4396* my/duj 601) mg/dhy p 00001 Study El BID study E2 study
Page 4: health.krhealth.kr/images/insert_pdf/IN_A11AOOOOO8538_00.pdf*acetin vs 40 20 300 Dose (mg/day) significant ßhown study E3 4396* my/duj 601) mg/dhy p 00001 Study El BID study E2 study

Statin Tolerability: Overcoming the Treatment Gap...rosuvastatin simvastatin 10 mg 20 mg 40 mg 80 mg 10 mg 20 mg 40 mg 80 mg 20 mg 40 mg 80 mg Proteinuria ≥ 2+ (%) 0.6% 2% 4% 0.4%

Statin Tolerability: Overcoming the Treatment Gap...rosuvastatin simvastatin 10 mg 20 mg 40 mg 80 mg 10 mg 20 mg 40 mg 80 mg 20 mg 40 mg 80 mg Proteinuria ≥ 2+ (%) 0.6% 2% 4% 0.4%

Documents
TCMG5:TCSMg-basedAlloysDatabase€¦ · Mg-Gd-Zr. TCMG5:TCSMg-basedAlloysDatabaseǀ5of81 Mg-In-Li Mg-In-Sn Mg-In-Zn Mg-La-Nd Mg-La-Ni Mg-La-Si Mg-La-Y Mg-Mn-Ni Mg-Mn-Sc Mg-Mn-Si Mg-Mn-Y

TCMG5:TCSMg-basedAlloysDatabase€¦ · Mg-Gd-Zr. TCMG5:TCSMg-basedAlloysDatabaseǀ5of81 Mg-In-Li Mg-In-Sn Mg-In-Zn Mg-La-Nd Mg-La-Ni Mg-La-Si Mg-La-Y Mg-Mn-Ni Mg-Mn-Sc Mg-Mn-Si Mg-Mn-Y

Documents
CLINICAL PHARMACOLOGY and BIOPHARMACEUTICS REVIEW … · Study CV 13172: Bioequivalence Study of 37.5 mg Irbesartan Tablets Relative to 37.5 mg Pediatric Small Tablets in Healthy

CLINICAL PHARMACOLOGY and BIOPHARMACEUTICS REVIEW … · Study CV 13172: Bioequivalence Study of 37.5 mg Irbesartan Tablets Relative to 37.5 mg Pediatric Small Tablets in Healthy

Documents
R LUNESTA (eszopiclone) TABLETS 1 mg, 2 mg, 3 mg · study in patients with insomnia; one in normal volunteers), the effects of LUNESTA 2 and 3 mg were assessed on 20 measures of cognitive

R LUNESTA (eszopiclone) TABLETS 1 mg, 2 mg, 3 mg · study in patients with insomnia; one in normal volunteers), the effects of LUNESTA 2 and 3 mg were assessed on 20 measures of cognitive

Documents
Study on Anisotropic Plastic Deformation of Mg-Alloys using

Study on Anisotropic Plastic Deformation of Mg-Alloys using

Documents
Rabakir 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 300 mg

Rabakir 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 300 mg

Documents
TXR#:0050460 II DATAEVALUATIONRECORD II SUBMISSION … › media › downloads › proposition...mg/kg/day [original study] and at 400 and 1000 mg/kg/day [supplemental study] from

TXR#:0050460 II DATAEVALUATIONRECORD II SUBMISSION … › media › downloads › proposition...mg/kg/day [original study] and at 400 and 1000 mg/kg/day [supplemental study] from

Documents
SABINSA CORPORATION - Herbamedica › media › forslean › 06-Forslean.pdf · forskohlii Extract (mg/day) [dose of forskolin (mg/day)] Study Design Study Length Measured Outcome(s)

SABINSA CORPORATION - Herbamedica › media › forslean › 06-Forslean.pdf · forskohlii Extract (mg/day) [dose of forskolin (mg/day)] Study Design Study Length Measured Outcome(s)

Documents
Research Article Study of the Gastroprotective Effect of ...downloads.hindawi.com/journals/ecam/2015/576495.pdf · EACm (mg/kg) EACm (100 mg/kg) EACm (200 mg/kg) EECm (mg/kg) EECm

Research Article Study of the Gastroprotective Effect of ...downloads.hindawi.com/journals/ecam/2015/576495.pdf · EACm (mg/kg) EACm (100 mg/kg) EACm (200 mg/kg) EECm (mg/kg) EECm

Documents
Clopidogrel 75 mg film-coated tablets Procedure No: … a crossover clinical study, clopidogrel (300-mg loading dose followed by 75 mg/day) alone and with omeprazole (80 mg at the

Clopidogrel 75 mg film-coated tablets Procedure No: … a crossover clinical study, clopidogrel (300-mg loading dose followed by 75 mg/day) alone and with omeprazole (80 mg at the

Documents
vamp - 약학정보원health.kr/images/insert_pdf/In_A11ABBBBB1214_01.pdf · 2016. 10. 11. · vamp: : Created Date: 6/12/2008 9:21:02 PM

vamp - 약학정보원health.kr/images/insert_pdf/In_A11ABBBBB1214_01.pdf · 2016. 10. 11. · vamp: : Created Date: 6/12/2008 9:21:02 PM

Documents
206353Orig1s000...Overall, the results of Study AI424511 support that administration of the ATV/cobi 300/150 mg oral FDC tablet and coadministration of ATV 300 mg plus cobi 150 mg

206353Orig1s000...Overall, the results of Study AI424511 support that administration of the ATV/cobi 300/150 mg oral FDC tablet and coadministration of ATV 300 mg plus cobi 150 mg

Documents
A double-blind, placebo-controlled study evaluating the effects of … double... · 2015. 11. 6. · consumers of caffeine each received 75 mg caffeine, 50 mg L-theanine, 75 mg caffeine

A double-blind, placebo-controlled study evaluating the effects of … double... · 2015. 11. 6. · consumers of caffeine each received 75 mg caffeine, 50 mg L-theanine, 75 mg caffeine

Documents
Daridorexant – Successful second pivotal study...Daridorexant is investigational, in development and not approved or marketed in any country. Study design. 25 mg. 10 mg. Placebo

Daridorexant – Successful second pivotal study...Daridorexant is investigational, in development and not approved or marketed in any country. Study design. 25 mg. 10 mg. Placebo

Documents
IUPUI Motorsports Engineering MG Feasibility Study

IUPUI Motorsports Engineering MG Feasibility Study

Economy & Finance
PharmARC SMMA Case Study on Aricept 23 mg - Public Citizen Petition

PharmARC SMMA Case Study on Aricept 23 mg - Public Citizen Petition

Health & Medicine
TABLETS - Stokes PharmacyMighty Bites.. 80 mg 150 mg Famciclovir Mini-Meds 31.25 mg 62.5 mg Fludrocortisone Mini-Meds 0.15 mg 0.25 mg 0.3 mg 0.4 mg 0.5 mg 0.6 mg 0.7 mg Fluoxetine

TABLETS - Stokes PharmacyMighty Bites.. 80 mg 150 mg Famciclovir Mini-Meds 31.25 mg 62.5 mg Fludrocortisone Mini-Meds 0.15 mg 0.25 mg 0.3 mg 0.4 mg 0.5 mg 0.6 mg 0.7 mg Fluoxetine

Documents
Bioequivalence Study of Sildenafil 20 mg Tablets in …...3 Bioequivalence Study of Sildenafil 20 mg ablets in ealthy ftai Male olunteers 240 ml of water after an overnight fasting

Bioequivalence Study of Sildenafil 20 mg Tablets in …...3 Bioequivalence Study of Sildenafil 20 mg ablets in ealthy ftai Male olunteers 240 ml of water after an overnight fasting

Documents
Ten 250 mg capsules of curcumin 95% - …€  Ten 250 mg capsules of curcumin 95% †† Ten 500 mg capsules of curcumin 95% *THESE ... pilot cross-over study to evaluate human oral

Ten 250 mg capsules of curcumin 95% - …€  Ten 250 mg capsules of curcumin 95% †† Ten 500 mg capsules of curcumin 95% *THESE ... pilot cross-over study to evaluate human oral

Documents
후루트만설명서 110513 [Converted]health.kr/images/insert_pdf/IN_A11APPPPP2704_00.pdf · 2016. 10. 11. · Title: 후루트만설명서_110513 [Converted] Created Date: 5/13/2011

후루트만설명서 110513 [Converted]health.kr/images/insert_pdf/IN_A11APPPPP2704_00.pdf · 2016. 10. 11. · Title: 후루트만설명서_110513 [Converted] Created Date: 5/13/2011

Documents
DISCOVER - 7Nutrition · L-Arginine 270 mg 2700 mg L-Lysine 200 mg 2000 mg L-Ornithine 195 mg 1950 mg Beta-Alanine 300 mg 3000 mg L-Citrulline 167,5 mg 1675 mg L-Carnitine Acetyl

DISCOVER - 7Nutrition · L-Arginine 270 mg 2700 mg L-Lysine 200 mg 2000 mg L-Ornithine 195 mg 1950 mg Beta-Alanine 300 mg 3000 mg L-Citrulline 167,5 mg 1675 mg L-Carnitine Acetyl

Documents
GROWTH HORMONE REFERRAL FORM Phone: 833.626.8417 • … · 0.2 mg 0.4 mg 0.6 mg 0.8 mg 1 mg 1.2 mg 1.4 mg 1.6 mg 1.8 mg 2 mg QTY: Refills: Humatrope Powder with Diluent Enroll in

GROWTH HORMONE REFERRAL FORM Phone: 833.626.8417 • … · 0.2 mg 0.4 mg 0.6 mg 0.8 mg 1 mg 1.2 mg 1.4 mg 1.6 mg 1.8 mg 2 mg QTY: Refills: Humatrope Powder with Diluent Enroll in

Documents
Final Report corrected 5 · COD/l, which were 0.222 mg/mg, 0.09 day-1, 1.20 day-1 and 659.45 mg COD/l for MLSS concentration of 3000 mg/l, respectively. The simulation study in predicting

Final Report corrected 5 · COD/l, which were 0.222 mg/mg, 0.09 day-1, 1.20 day-1 and 659.45 mg COD/l for MLSS concentration of 3000 mg/l, respectively. The simulation study in predicting

Documents
A comprehensive study of Al-Cu-Mg system reinforced with

A comprehensive study of Al-Cu-Mg system reinforced with

Documents
Metadate CD (methylphenidate HCl, USP) Extended-Release ... · mg (6 mg IR; 14 mg ER), 30 mg (9 mg IR; 21 mg ER), 40 mg (12 mg IR; 28 mg ER), 50 mg (15 mg IR; 35 mg ER), or 60 mg

Metadate CD (methylphenidate HCl, USP) Extended-Release ... · mg (6 mg IR; 14 mg ER), 30 mg (9 mg IR; 21 mg ER), 40 mg (12 mg IR; 28 mg ER), 50 mg (15 mg IR; 35 mg ER), or 60 mg

Documents
Steve-oh-mg Creative Advertising Message Expression Case Study Samples

Steve-oh-mg Creative Advertising Message Expression Case Study Samples

Marketing
Abstract 4649 ODM-207, a novel BET-bromodomain inhibitor ... · with ODM-207 30 mg/kg qd, iBET-762 30 mg/kg qd, OTX-015 40 mg/kg qd, enzalutamide 20 mg/kg qd (only efficacy study)

Abstract 4649 ODM-207, a novel BET-bromodomain inhibitor ... · with ODM-207 30 mg/kg qd, iBET-762 30 mg/kg qd, OTX-015 40 mg/kg qd, enzalutamide 20 mg/kg qd (only efficacy study)

Documents
Comparative Study on the Remediation Potential of …...concentrations 5 mg/kg, 10 mg/kg, 20 mg/kg and 40 mg/kg in triplicates and control was setup. After 4 months, the plants (root,

Comparative Study on the Remediation Potential of …...concentrations 5 mg/kg, 10 mg/kg, 20 mg/kg and 40 mg/kg in triplicates and control was setup. After 4 months, the plants (root,

Documents
201917Orig1s000 - Food and Drug Administration · Infected Subjects Dosed with the 250-mg Tablet in Study 101** **The 450-mg and 750-mg doses were given q8h and the 1250-mg dose was

201917Orig1s000 - Food and Drug Administration · Infected Subjects Dosed with the 250-mg Tablet in Study 101** **The 450-mg and 750-mg doses were given q8h and the 1250-mg dose was

Documents
74 0 150 75 mg -150 (Iffi 25 72 mc/d) 2) Lapp (oooied O,health.kr/images/insert_pdf/IN_2011102600013_00.pdf · 72 mc/d) 2) Lapp (oooied O, — Q.430/0B0üi 24 01 Cupportive G); 36711

74 0 150 75 mg -150 (Iffi 25 72 mc/d) 2) Lapp (oooied O,health.kr/images/insert_pdf/IN_2011102600013_00.pdf · 72 mc/d) 2) Lapp (oooied O, — Q.430/0B0üi 24 01 Cupportive G); 36711

Documents